Get started
Author

Seong Cheol Min

Observed name: Min, Seong Cheol
ORCID: 0000-0001-8262-990X
Observed ORCID: 0000-0001-8262-990X
OpenAlex ID: A5016901288
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
2022 · Ju Hwan Jeong, Santosh Chokkakula, et al. · Antiviral Research · 72
PDF
A Rapid Method for Generating Infectious SARS-CoV-2 and Variants Using Mutagenesis and Circular Polymerase Extension Cloning
2023 · Beom Kyu Kim, Won-Suk Choi, et al. · Microbiology Spectrum · 13
PDF
Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronaviruses
2023 · Ju Hwan Jeong, Jang-Hoon Choi, et al. · Antiviral Research · 7
Development of a Universal Cloning System for Reverse Genetics of Human Enteroviruses
2023 · Won-Suk Choi, Sol Oh, et al. · Microbiology Spectrum · 7
Mammalian adaptation risk in HPAI H5N8: a comprehensive model bridging experimental data with mathematical insights
2024 · Santosh Chokkakula, Sol Oh, et al. · Emerging Microbes & Infections · 4
A SARS-CoV-2 Mpro mutation conferring ensitrelvir resistance paradoxically increases nirmatrelvir susceptibility
2025 · Seong Cheol Min, Jin-Ju Seo, et al. · Nature Communications · 3
PDF
High-throughput in vitro screening and in silico analysis for Zika virus inhibitor identification
2025 · Sania Batool, Santosh Chokkakula, et al. · Scientific Reports · 2
PDF
Evaluation of the Antiviral Efficacy of Subcutaneous Nafamostat Formulated with Glycyrrhizic Acid against SARS-CoV-2 in a Murine Model
2023 · Ju Hwan Jeong, Woong Hee Lee, et al. · International Journal of Molecular Sciences · 2
PDF
MG-101, a cysteine protease inhibitor identified through high-throughput screening, exhibits in vivo efficacy and synergy with remdesivir against SARS-CoV-2
2026 · Jinyeong Heo, Soonju Park, et al. · Biomedicine & Pharmacotherapy · 1
Portable RT-LAMP Platform for Rapid Point-of-Care Detection for SFTSV
2025 · Gi Chan Lee, Beom Kyu Kim, et al. · Journal of Microbiology and Biotechnology · 1
PDF
Therapeutic applications of interface-mimicking peptides for targeting the SARS-CoV-2 NSP12-NSP8 RdRp complex
2025 · Mark Anthony B. Casel, Jae-Woo Ahn, et al. · Molecular Therapy · 1
Regorafenib as a potential drug for severe COVID ‐19: inhibition of inflammasome activation in mice
2025 · Ju Hwan Jeong, Sun‐Ok Kim, et al. · FEBS Open Bio · 1
PDF
Comparison of Baloxavir-Based Combinations and Monotherapies for Treating Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Mice
2026 · Seong Cheol Min, Ju Ryeong Lee, et al. · Emerging infectious diseases
Capless self-amplifying mRNA vaccine induces dose-sparing protective immunity against HPAI clade 2.3.4.4 H5 virus in mice
2026 · Beom Kyu Kim, Ji-Hyun Park, et al. · Molecular Therapy
A SARS-CoV-2 Mpro mutation conferring ensitrelvir resistance paradoxically increases nirmatrelvir susceptibility
2025 · Min-Suk Song, Seong Cheol Min, et al. · Research Square
PDF
Mosaic display of stable hemagglutinin monomers induces broad immune responses
2024 · Hyojin Kim, Seong Cheol Min, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Mammalian Adaptation Risk in HPAI H5N8:: A Comprehensive Model Bridging Experimental Data with Mathematical Insights
2023 · Santosh Chokkakula, Sol Oh, et al. · SSRN Electronic Journal
Works count: 18
Citation count: 114
H-index: 4
I10-index: 2
Year
Topic
Type